Announcement
23 Jun 2022
In June 2022, Osivax raised EUR 10 million (USD 10.5 million) from Bpifrance for the development of a new influenza shot.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
23 Jun 2022
Revocation date:
No revocation date
Updated: 23 Jun 2022
Financial grant
In force
On 23 June 2022, the Public Investment Bank and Export Credit Agency of France, Bpifrance, granted a EUR 10 million (USD 10.5 million) financial grant to Osivax for the development of the new unive...
Sign in to see more
Threads
See all
This state act is not part of any Thread yet.